On Orbit Immuno-Based, Label-Free, White Blood Cell Counting System with MicroElectroMechanical Sensor (MEMS) Technology (OILWBCS-MEMS)

Award Information
Agency: National Aeronautics and Space Administration
Branch: N/A
Contract: NNX10CB07C
Agency Tracking Number: 084136
Amount: $599,988.00
Phase: Phase II
Program: SBIR
Awards Year: 2010
Solicitation Year: 2008
Solicitation Topic Code: X14.02
Solicitation Number: N/A
Small Business Information
Aurora Flight Sciences Corporation
9950 Wakeman Drive, Manassas, VA, 20110-2702
DUNS: 604717165
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Jessica Edmonds
 Principal Investigator
 (617) 500-0552
 jedmonds@auror.aero
Business Contact
 Scott Hart
Title: Financial Analyst
Phone: (617) 500-0536
Email: shart@aurora.aero
Research Institution
N/A
Abstract
Aurora Flight Sciences Corporation and partner, Draper Laboratory, propose to develop an on-orbit immuno-based label-free white blood cell counting system using MEMS technology (OILWBCS-MEMS) for human spaceflight experimental and medical monitoring practices. Our proposed system is designed to meet NASA's requirements for a microgravity compatible, miniaturized, light weight peripheral blood cell counting instrument capable of on-orbit cell counting, without high energy lasers, requiring minimal sample volume or exogenous (sheath) fluid, and generating minimal bio-hazardous waste: SBIR topic X14.02 "On Orbit Cell Counting and Analysis Capability". The proposed detection technology leverages changes in optical transmission through a surface due to molecular binding (e.g., antibody-antigen binding). Antibodies specific to the white blood cell surface protein markers (antigens) are pre-coated on the sensor surface to recognize specific white blood cell types with inherently high specificity and sensitivity. In Phase I we developed surface chemistry and demonstrated surface chemistry sensitivity and specificity for total white blood cells and two lymphocyte subtypes (B-cells, CD4+ T-cells). During phase II we will develop a functional prototype of the OILWBCS-MEMS device to demonstrate that end-to-end operations from sample-in to signal-out produces clinically relevant results. The OILWBCS-MEMS design will include single-use replaceable cartridges for fluid loop and sensor components.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government